Skip to main navigation

Visit Natera.com

Governance
Stock Information
Financial Information
Key Resources
Search for:
Visit Natera.com

Event Details

Natera, Inc. Q1 2022 Earnings Conference Call

May 5, 2022 4:30 PM EDT

Click here for webcast

Supporting Materials

Natera, Inc. Q1 2022 Earnings Presentation 2.8 MB

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
- About Us
- Our People
- Our Technology
- News
- Events
- Careers
- Investor Relations
Contact

Natera Licenses
Natera Notice of Data Collection for California Residents
Privacy Practices
Privacy Policy
Terms of Use
Sitemap

Designed by Elegant Themes | Powered by WordPress

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). Although FDA is exercising enforcement discretion of premarket review and other regulations for laboratory-developed tests in the US, certification of the laboratory is required under CLIA to ensure the quality and validity of the tests. CAP accredited, ISO 13485 certified, and CLIA certified. © 2022 Natera, Inc. All Rights Reserved.